These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16910883)

  • 1. Graves' disease and coexisting struma ovarii: struma expression of thyrotropin receptors and the presence of thyrotropin receptor stimulating antibodies.
    Teale E; Gouldesbrough DR; Peacey SR
    Thyroid; 2006 Aug; 16(8):791-3. PubMed ID: 16910883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of Graves' disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature.
    Anastasilakis AD; Ruggeri RM; Polyzos SA; Makras P; Molyva D; Campennì A; Gkiomisi A; Balaris C; Fotiadis PP; Tuccari G; Papachatzopoulos S
    Metabolism; 2013 Oct; 62(10):1350-6. PubMed ID: 23806737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of Graves' disease and struma ovarii: case report and literature review.
    Mimura Y; Kishida M; Masuyama H; Suwaki N; Kodama J; Otsuka F; Kataoka H; Yamauchi T; Ogura T; Kudo T; Makino H
    Endocr J; 2001 Apr; 48(2):255-60. PubMed ID: 11456276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of Graves' disease and unilateral functioning Struma ovarii: a case report.
    Sitasuwan T; Hanamornroongruang S; Peerapatdit T; Thongtang N
    BMC Endocr Disord; 2015 Nov; 15():68. PubMed ID: 26530865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperthyroidism during pregnancy due to coexistence of struma ovarii and Graves' disease.
    Kung AW; Ma JT; Wang C; Young RT
    Postgrad Med J; 1990 Feb; 66(772):132-3. PubMed ID: 2349185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant struma ovarii with Graves' disease.
    Kano H; Inoue M; Nishino T; Yoshimoto Y; Arima R
    Gynecol Oncol; 2000 Dec; 79(3):508-10. PubMed ID: 11104630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthyroidism due to coexistence of Graves' disease and Struma ovarii.
    Chiofalo MG; Misso C; Insabato L; Lastoria S; Pezzullo L
    Endocr Pract; 2007; 13(3):274-6. PubMed ID: 17599859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of struma ovarii and Graves' disease.
    Bayot MR; Chopra IJ
    Thyroid; 1995 Dec; 5(6):469-71. PubMed ID: 8808098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of malignant struma ovarii and Graves' disease.
    Sussman SK; Kho SA; Cersosimo E; Heimann A
    Endocr Pract; 2002; 8(5):378-80. PubMed ID: 15251841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of Graves' disease and benign struma ovarii in a patient with marked ascites and elevated CA-125 levels.
    Guida M; Mandato VD; Di Spiezio Sardo A; Di Carlo C; Giordano E; Nappi C
    J Endocrinol Invest; 2005 Oct; 28(9):827-30. PubMed ID: 16370564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure T3 thyrotoxicosis from a Struma Ovarii characterised by a paradoxical rise in thyroxine on treatment.
    Prentice J; Panter K; Attygalle A; Ind T; Prentice M
    Endocrinol Diabetes Metab Case Rep; 2020 Mar; 2020():. PubMed ID: 32168467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Struma ovarii associated with Graves' disease].
    Pastorino Casas V; Borghi Torzillo MF; Schere D; Lutfi RJ; Faure EN
    Medicina (B Aires); 2018; 78(1):44-46. PubMed ID: 29360077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotoxic adenoma followed by atypical hyperthyroidism due to struma ovarii: clinical and genetic studies.
    Ciccarelli A; Valdes-Socin H; Parma J; Khoo SK; Schoumans J; Colao A; Hamoir E; Beckers A
    Eur J Endocrinol; 2004 Apr; 150(4):431-7. PubMed ID: 15080771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe ophthalmopathy developing after treatment of coexisting malignant struma ovarii and Graves' disease.
    Wong LY; Diamond TH
    Thyroid; 2009 Oct; 19(10):1125-7. PubMed ID: 19772400
    [No Abstract]   [Full Text] [Related]  

  • 17. Struma ovarii: a case report.
    Lazarus JH; Richards AR; MacPherson MJ; Dinnen JS; Williams ED; Owen GM; Wade JS
    Clin Endocrinol (Oxf); 1987 Dec; 27(6):715-20. PubMed ID: 3455373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibodies reactive with eye muscle antigens and the TSH receptor in a euthyroid subject who developed ophthalmopathy and Graves' hyperthyroidism.
    Wall J; Barsouk A; Stolarski C; Kiljanski J; Stachura I; Nebes V; Peele K; Volpe R; Kennerdell J
    Thyroid; 1996 Aug; 6(4):353-8. PubMed ID: 8875760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
    Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Struma ovarii and the thyroid surgeon.
    Gunasekaran S; Kopecka E; Maung KH; England RJ
    J Laryngol Otol; 2012 Aug; 126(8):858-60. PubMed ID: 22624934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.